Strongest evidence
The most studied outcome for beta-alanine is improved physical performance, but the evidence is still rated as low. Across 4 studies, 2 reported small beneficial effects and 2 reported neutral effects; only 2 of the 4 reached statistical significance. The median study duration was 28 days (based on a single study), and one study used 6.4 g/day in military personnel. No consistent dose range emerged due to poor reporting.
Mixed or weaker evidence
For reduced heart rate, the evidence is uniformly neutral. All 3 studies (in middle-distance runners and swimmers) showed small, non-significant effects, with no beneficial results. This outcome has even less support than physical performance.
Effective dose patterns
Across both outcomes, the most commonly mentioned dose was 6.4 g/day (either as a daily dose for 28 days or taken acutely). However, because many studies did not report dosing or duration, no reliable dose–response relationship can be established from the current evidence.
Population insights
The research has focused on physically active populations: athletes (middle-distance runners, swimmers) and military personnel. There is no evidence in elderly or general populations, nor in any deficient group.
Notable caveats
Both outcome syntheses are based on a small number of studies (4 and 3), and all evidence is rated low strength. Conclusions should be considered preliminary. A substantial portion of studies did not reach statistical significance, and many lacked adequate reporting of dose and duration. These limitations make it difficult to draw firm conclusions about beta-alanine’s effectiveness.